Cellular and molecular biology of the liver

Current Opinion in Gastroenterology

Volumn 15, Issue 3, 1999, Pages 184-191

  Karpen, Saul J ^a   Crawford, James M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

APOPTOSIS; CELL COMMUNICATION; CELL JUNCTION; CYTOLOGY; FUNCTIONAL ANATOMY; HEPATOBILIARY SYSTEM; INFLAMMATORY CELL; LIVER; LIVER PARENCHYMA; MEDIATOR; MOLECULAR BIOLOGY; REVIEW;

EID: 0033033563     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199905000-00002     Document Type: Review

References (93)

1. Gong WR, Roth S, Michel K, Gressner AM: Isoforms and splice variant of transforming growth factor b-binding protein in rat hepatic stellate cells. Gastroenterology 1998, 114:352-363.
2. Wang SC, Ohata M, Schrum L, Rippe RA, Tsukamoto H: Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 1998, 273:302-308.
3. Knolle PA, Uhrig A, Protzer U, Trippler M, Duchmann R, Zum Buschenfelde KHM, Gerken G: Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology 1998, 27:93-99.
4. Zhu NL, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MMC: Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998, 72:3691-3697. The HCV core protein binds to the cytoplasmic domain of the lymphotoxin β receptor, a member of the TNFR family. This study now shows that the HCV core protein also binds to the cytoplasmic domain of TNFR1. These results raise the possibility that HCV interaction with TNF-α signaling pathways plays a role in the regulation of cell death.
5. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R: Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem 1998, 273:2256-2259. To explore the effects of the HCV on hepatocyte proliferation, the authors tested the effect of expressing the HCV core protein in a human breast carcinoma cell line on TNF-α-induced apoptosis. The HCV core protein reduced TNF-α-induced apoptotic cell death by apparently inhibiting the TNF-α-mediated cell death signaling pathway. This may provide a selective advantage for HCV replication, allowing evasion of host antiviral defense mechanisms.
6. Kallinowski B, Haseroth K, Marines G, Hanck C, Stremmel W, Theilmann L, Singer MV, Rossol S: Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998, 111:269-277.
7. Ortega D, Pol A, Biermer M, Jäckle S, Enrich C: Annexin VI defines an apical endocytic compartment in rat liver hepatocytes. J Cell Sci 1998, 111:261-269. Annexin VI is a marker for hepatic endosomes; this study demonstrates that it is associated predominantly with endocytic structures surrounding the hepatocyte bile canaliculus. This, then, is the first known structural protein at the apical "early" endosomal compartment. This membrane retrieval pathway is important for the regulation of protein content and membrane composition of the canalicular domain.
8. Fujita H, Tuma PL, Finnegan CM, Locco L, Hubbard AL: Endogenous syntaxins 2, 3 and 4 exhibit distinct but overlapping patterns of expression at the hepatocyte plasma membrane. Biochem J 1998, 329:527-538.
9. Yoon Y, Tǒrǒk N, Krueger E, Oswald B, McNiven MA: Ethanol-induced alterations of the microtubule cytoskeleton in hepatocytes. Am J Physiol Gastrointest Liver Physiol 1998, 274:G757-G766. Ethanol inhibits hepatocellular secretion of serum proteins in part by disrupting intracellular microtubule-dependent trafficking pathways. The authors demonstrate that ethanol does not impair cellular expression of the constituent protein, tubulin. Rather, the tubulin in livers chronically exposed to ethanol is incapable of assembling into tubules. This may help explain the markedly deranged cytoskeletal structure of ethanol-exposed hepatocytes.
10. 125I-labeled photoreactive ceramide as a biosynthetic precursor of sphingomyelin, the authors demonstrated in HepG2 cells that a 60 kDa cellular protein appeared to play a specific functional role in the transportation of sphingolipids to the bile canalicular membrane. The exact nature of the putative proteins involved remains to be elucidated, but may be important for studies of hepatocyte polarity and bile secretion.
11. Ludwig J, Ritman EL, LaRusso NF, Sheedy PF, Zumpe G: Anatomy of the human biliary system studied by quantitative computer-aided three-dimensional imaging techniques. Hepatology 1998, 27:893-899. Three-dimensional reconstruction of normal adult human livers was performed to define the branching anatomy of the biliary system. On the basis of branching, approximately seven orders of intrahepatic ducts were observed, with the terminal ramifications extending beyond the portal tracts into the hepatic parenchyma. The detailed measurements obtained in this study will be extremely useful for the future investigation of site-restricted function of epithelial cells lining the biliary tree.
12. Crawford AR, Lin X-Z, Crawford JM: The adult human liver biopsy: A quantitative reference standard. Hepatology 1998, 28:323-331.
13. Ekataksin W, Wake K: New concepts in biliary and vascular anatomy of the liver. Prog Liver Dis 1997, in press.
14. Bhunchet E, Wake K: The portal lobule in rat liver fibrosis: A re-evaluation of the liver unit. Hepatology 1998, 27;481-487.
15. Faa G, Van Eyken P, Roskams T, Miyazaki H, Serreli S, Ambu R, Desmet VJ: Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation. J Hepatol 1998, 29:628-833.
16. Alpini G, Glaser SS, Ueno Y, Pham L, Podila PV, Caligiuri A, LeSage G, LaRusso NF: Heterogeneity of the proliferative capacity of rat cholangiocytes after bite duct ligation. Am J Physiol 1998, 274:G767-G775.
17. Song JY, Van Noorden CJF, Frederiks WM: Rearrangement of hepatocellular F-actin precedes the formation of rosette-like structures in parenchyma of cholestatic rat liver. Hepatology 1998, 27:765-771.
18. Jakubczak JL, Chisari FV, Merino G: Synergy between transforming growth factor α and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. Cancer Res 1997, 57:3606-3611.
19. Crosby HA, Hubscher S, Fabris L, Joplin R, Sell S, Kelly D, Strain AJ: Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 1998, 152:771-779. The putative hepatic cells responsible for repopulating the liver after severe injury, so-called stem cells or progenitor cells, have been difficult to identify in the human liver. Using livers from patients with end-stage biliary tract disease, the authors demonstrated the presence of cells immunoreactive for hepatocyte and/or bile duct markers. Such cells were essentially absent in normal livers. This study indicates that bipotential progenitor cells are indeed present in the human liver and that the antibody OV-6 is useful for their identification.
20. Sell S: Comparison of liver progenitor cells in human atypical ductular reactions with those seen in experimental models of liver injury. Hepatology 1998, 27:317-331. In examining human livers exhibiting the ductular proliferative response characteristic of severe parenchymal injury, Sell finds that white primitive progenitor cells may exist, there are a variety of different proliferating cells on the basis of morphology. These morphologic findings leave open the possibility that proliferating populations of stem cells within the liver may be very different from one another under various disease conditions.
21. Petersen BE, Zajac VF, Michalopoulos GK: Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 1998, 27:1030-1038.
22. Olynyk JK, Yeoh GC, Ramm GA, Clarke SL, Hall PDLM, Britton RS, Bacon BR, Tracy TF: Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. Am J Pathol 1998, 152:347-352.
23. Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK: Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998, 27:433-445.
24. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, et al.: Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997, 16:235-242. Alagille syndrome is an autosomal dominant disorder characterized by intrahepatic cholestasis and abnormalities of the heart, eye, vertebrae, and facial features. This report maps the gene locus for Alagille syndrome to a 250 kb region of chromosome 20p. Within this region a candidate gene, JAG1, was identified. JAG1 is the human homologue of rat Jagged1, which encodes a ligand for the Notch receptor. As cell-cell Jagged1:Notch interactions appear to be critical determinants of cell fate in developing embryos, this discovery indicates that haploinsufficiency of JAG1 can have wide-ranging effects on tissue formation and function.
25. Eugenin EA, Gonzalez H, Saez CG, Saez CS: Gap junctional communication coordinates vasopressin-induced glycogenolysis in rat hepatocytes. Am J Physiol 1998, 274:G1109-G1116.
26. Temme A, Traub O, Willecke K: Downregulation of connexin32 protein and gap-junctional intercellular communication by cytokine-mediated acute-phase response in immodalized mouse hepatocytes. Cell Tissue Res 1998, 294:345-350.
27. Hossain MZ, Ao P, Boynton AL: Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liver epithelial cells expressing platelet-derived growth factor receptor. J Cell Physiol 1998, 174:66-77.
28. 2+ signaling in neonatal and adult rat hepatocyte doublets. J Hepatol 1998, 28:221-230.
29. Roman RM, Wang Y, Lidofsky SD, Feranchak AP, Lomri N, Scharschmidt BF, Fitz JG: Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 1997, 272:21970-21976.
30. Schlenker T, Romac JMJ, Sharara AI, Roman RM, Kim SJ, LaRusso N, Liddle RA, Fitz JG: Regulation of biliary secretion through apical purinergic receptors in cultured rat cholangiocytes. Am J Physiol Gastrointest Liver Physiol 1997, 273:G1108-G1117.
31. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wang MH, Dawson PA: Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 1998, 274:G157-G169.
32. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y: Increased expression of interleukin-6 and tumor necrosis factor-α in pathologic biliary epithelial cells: In situ and culture study. Lab Invest 1998, 78:89-100.
33. Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ: Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a Type I ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 1998, 28:1260-1268. Biliary epithelial cell proliferation is stimulated by the IL-6:GP-80 and hepatocyte growth factor:met ligand:receptor systems. Using bile duct ligation to stimulate bile ductular proliferation, the authors demonstrate that periductal lymphoid and stromal cells are the source of biliary epithelial cell growth factors, with concomitant upregulation of biliary epithelial cell receptors. Such interactions among inflammatory, stromal, and biliary epithelial cells result in dysmorphic repair responses, which may play a role in the development of cirrhosis.
34. Crawford JM: Cellular and molecular biology of the inflamed liver. Curr Opin Gastroenterol 1997, 13:175-185.
35. Cutrin JC, Llesuy S, Boveris A: Primary role of Kupffer cell-hepatocyte communication in the expression of oxidative stress in the post-ischaemic liver. Cell Biochem Funct 1998, 16:65-72.
36. Rockey DC, Fouassier L, Chung JJ, Carayon A, Valise P, Rey C, Housset C: Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells. Hepatology 1998, 27:472-480.
37. Roth S, Michel K, Gressner AM: (Latent) transforming growth factor β in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 1998, 27:1003-1012.
38. Myers KJ, Eppihimer MJ, Hall L, Wolitzky B: Interleukin-12-induced adhesion molecule expression in murine liver. Am J Pathol 1998, 152:457-468.
39. Essani NA, Fisher MA, Simmons CA, Hoover JL, Farhood A, Jaeschke H: Increased P-selectin gene expression in the liver vasculature and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Leukocyte Biol 1998, 63:288-296.
40. 4-induced injury.
41. Chosay JG, Fisher MA, Farhood A, Ready KA, Dunn CJ, Jaeschke H: Role of PECAM-1 (CD31) in neutrophil transmigration in murine models of liver and peritoneal inflammation. Am J Physiol 1998, 274:G776-G782.
42. Maher JJ, Lozier JS, Scott MK: Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am J Physiol 1998, 275:G847-G853.
43. Hill DA, Roth RA: A-naphthylisothiocyanate causes neutrophils to release factors that are cytotoxic to hepatocytes. Toxicol Appl Pharmacol 1998, 148;169-175.
44. Salmi M, Adams D, Jalkanen S: Cell adhesion and migration-IV. Lymphocyte trafficking in the intestine and liver. Am J Physiol 1998, 274:G1-G6.
45. Norris S, Collins C, Doherty DG, Smith F, McEntee G, Traynor O, Nolan N, Hegarty J, O'Farrelly C: Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998, 28:84-90.
46. Arenz M, Zum Büschenfelde KHM, Löhr HF: Limited T cell receptor Vb-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis. J Hepatol 1998, 28:70-77.
47. Honda A, Salen G, Nguyen LB, Xu GR, Tint GS, Batta AK, Shefer S: Regulation of early cholesterol biosynthesis in rat liver: Effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and aceteacetyl coenzyme A thiolase activities. Hepatology 1998, 27:154-159.
48. Rudling M, Parini P, Angelin B: Growth hormone and bile acid synthesis - Key role for the activity of hepatic microsomal cholesterol 7a-hydroxylase in the rat. J Clin Invest 1997, 99:2239-2245.
49. Agellon LB, Cheema SK; The 3′-untranslated region of the mouse cholesterol 7a-hydroxylase mRNA contains elements responsive to post-transcriptional regulation by bile acids. Biochem J 1997, 328:393-399.
50. Pandak WM, Heuman DM, Redford K, Stravitz RT, Chiang JYL, Hylemon PB, Vlahcevic ZR: Hormonal regulation of cholesterol 7a-hydroxylase specific activity, mRNA levels, and transcriptional activity in vivo in the rat. J Lipid Res 1997, 38:2483-2491.
51. Izem L, Rassart E, Kamate L, Falstrault L, Rhainds D, Brissette L: Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism. Biochem J 1998, 329:81-88.
52. Hill SA, McQueen J: Reverse cholesterol transport-a review of the process and its clinical implications. Clin Biochem 1997, 30:517-525.
53. Robins SJ, Fasulo JM: High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. J Clin Invest 1997, 99:380-384.
54. Wanon J, Guertin F, Brunet S, Delvin E, Gavino V, Bouthillier D, Lairon D, Yotov W, Levy E: The effects of cholesterol uptake from high-density lipoprotein subtractions on biliary sterol secretion in rats with essential fatty-acid deficiency. Hepatology 1998, 27:779-786.
55. Woollett LA, Keamey DM, Spady DK: Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster. J Lipid Res 1997, 38;2289-2302.
56. Jolley CD, Woollett LA, Turley SD, Dietschy JM: Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipeprotein A-I concentration. J Lipid Res 1998, 39:2143-2149.
57. Fluiter K, Van Berkel TJC: Scavenger receptor B1 (SR-B1) substrates inhibit the selective uptake of high-density-lipoprotein cholesteryl esters by rat parenchymal liver cells. Biochem J 1997, 326:515-519.
58. Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, Gosselin ML, Dixon KL, Deeds JD, Acton SL, Tall AR, Huszar D: Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1998, 95:4619-4624.
59. Jian B, De la Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH: Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 1998, 273:5599-5606.
60. Fluiter K, Van der Westhuijzen DR, Van Berkel TJC: In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells. J Biol Chem 1998, 273:8434-8438.
61. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M: Overexpression of the HDL receptor SR-B1 alters plasma HDL and bile cholesterol levels. Nature 1997, 387:414-417.
62. Wang DQH, Paigen B, Carey MC: Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: Physical-chemistry of gallbladder bile. J Lipid Res 1997, 38:1395-1411.
63. Fuchs M, Lammert F, Wang DQH, Paigen B, Carey MC, Cohen DC: Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice. Biochem J 1998, 336:33-37. Improving somatic gene expression by altering chromosomal sequences has been a prime goal of gene therapy. The authors provide the exciting information that they can mutate specific chromosomal sequences via injection of an artificial oligonucleotide. This model may well be the best hope yet to reliably and safely deliver permanent changes to hepatic genes possessing single nucleotide mutations.
64. Patel T, Roberts LR, Jones BA, Gores GJ: Dysregulation of apoptosis as a mechanism of liver disease: An overview. Semin Liver Dis 1998, 18:105-114. A comprehensive compilation of the information available regarding the mediators of apoptosis in hepatocytes and bile duct cells. The authors provide an exploration of the role of apoptosis in hepatobiliary diseases in which cell death is a prominent feature. This overview complements articles in the same issue regarding the specific role of apoptosis in liver diseases.
65. Maher JJ, Gores GJ: Apoptosis: Silent killer or neutron bomb? Hepatology 1998, 28:865-867.
66. Gores GJ, Miyoshi H, Botla R, Aguilar HI, Bronk SF: Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: A potential role for mitochondrial proteases. Biochim Biophys Acta 1998, 1368:167-175. These authors previously have provided support for the role of hydrophobic bile acids as pro-apoptotic agents. Using the model of GCDC-induced apoptosis, they provide evidence for activation of the mitochondrial MPT as a central mediator of apoptotic signals. Moreover, activation of mitochondrial proteases could be the initiating event. Finally, UDCA's role in abrogating the effects of GCDC is presented as a potential explanation of the clinical usefulness of UDCA in chronic cholestatic conditions.
67. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ: A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998, 101:2790-2799. A number of substances other than hydrophobic bile acids can induce apoptosis in hepatocytes. The authors indicate that ethanol, cytokines, and Fas ligand all lead to apoptosis by inducing the mitochondrial MPT. Moreover, UDCA treatment interfered with the MPT from several different inducers, and thereby inhibited apoptosis. These data provide an intriguing suggestion that the hydrophilic bile acid UDCA can function as an anti-apoptotic agent by directly interfering with the MPT.
68. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ: Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998, 4:165-178.
69. Benz C, Angermuller S, Kloters-Plachky P, Sauer P, Stremmel W, Stiehl A: Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes. Eur J Clin Invest 1998, 28:577-583.
70. Benz C, Angermuller S, Tox U, Kloters-Plachky P, Riedel HD, Sauer P, Stremmel W, Stiehl A: Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol 1998, 28:99-106.
71. Waxman DJ: Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. J Endocrinol 1996, 150(suppl):S129-S147.
72. Latruffe N, Vamecq J: Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie 1997, 79:81-94.
73. Clarke SD, Jump DB: Polyunsaturated fatty acid regulation of hepatic gene transcription. J Nutr 1996, 126:1105S-1109S.
74. Mangelsdoff DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al.: The nuclear receptor superfamily: The second decade. Cell 1995, 83:835-839.
75. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
76. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangeisdoff DJ: LXR, a nuclear receptor that defined a distinct retinoid response pathway. Genes Dev 1995, 9:1033-1045.
77. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ: Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93:693-704. Ascribing function to the recently expanding array of orphan nuclear receptors has become a focus of laboratory investigations worldwide. The LXRα receptor is highly expressed in hepatocytes and activated by intermediates of cholesterol synthesis. The authors have developed a knockout of the locus and determined that the homozygous knockout mice have significant impairments in both cholesterol and bile acid metabolism. Moreover, these mice are unable to transform excess cholesterol into bile acids, primarily because LXRα is a critical transactivator of the CYP7a promoter. Thus, homozygous LXRα -/- animals accumulate dietary cholesterol in their livers and cannot increase bile acid synthesis. These findings have significant implications for our understanding of the coordinating regulators of cholesterol and bile acid metabolism.
78. Chiang JYL: Regulation of bile acid synthesis. Front Biosci 1998, 3:D176-D193.
79. Crestani M, Sadeghpour A, Stroup D, Galli G, Chiang JY: Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone. J Lipid Res 1998, 39:2192-2200.
80. Crestani M, Sadeghpour A, Stroup D, Galli G, Chiang JY: The opposing effects of retinoic acid and phorbol esters converge to a common response element in the promoter of the rat cholesterol 7 alpha-hydroxylase gene (CYP7A). Biochem Biophys Res Commun 1996, 225:585-592.
81. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998, 102:1016-1023.
82. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T, Lehmann JM: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998, 92:73-82.
83. Blumberg B, Evans RM: Orphan nuclear receptors-new ligands and new possibilities. Genes Dev 1998, 12:3149-3155.
84. Blumberg B, Sabbagh, Jr W, Juguilon H, Borado, Jr J, van Meter CM, Ong ES, Evans RM: SXR, a novel steroid and xenobionic-sensing nuclear receptor. Genes Dev 1998, 12:3195-3205. This liver-enriched orphan nuclear receptor possesses the intriguing characteristic of being activated by a wide variety of ligands that induce the drug-metabolizing enzyme CYP3A4. SXR activation by certain compounds can help explain the clinical observation that drugs such as rifampin and phenobarbital can themselves affect the metabolism of other unrelated co-administered drugs. These two agents are activators of SXR and, therefore, inducers of CYP3A4. It is likely that the gene cloned in [81] is highly related to SXR. These findings are likely to assist greatly in the investigation and development of new drugs and provide a deeper understanding of their metabolism.
85. Falasca L, Favale A, Serafino A, Ara C, Conti Devirgiliis L: The effect of retinoic acid on the re-establishment of differentiated hepatocyte phenotype in primary culture. Cell Tissue Res 1998, 293:337-347.
86. Steineger HH, Arntsen BM, Spydevold O, Sorensen HN: Gene transcription of the retinoid X receptor alpha (RXRalpha) is regulated by fatty acids and hormones in rat hepatic cells. J Lipid Res 1998, 39:744-754.
87. Taub R: Liver regeneration 4: Transcriptional control of liver regeneration. FASEB J 1996, 10:413-427.
88. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R: Liver failure and defective hepatocyte regeneration in interteukin-6-deficient mice. Science 1996, 274:1379-1383.
89. Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, Taub R: CCAAT enhancer-binding protein beta is required for normal bepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998, 102:996-1007.
90. Yamada Y, Fausto N: Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 1998, 152:1577-1589.
91. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N; Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 1998, 28:959-970.
92. Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C, Shinozuka H, Bluethmann H, Poli V, Ciliberto G, Columbano A: In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 1998, 17:1039-1044.
93. Kren BT, Bandyopadhyay P, Steer CJ: In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 1998, 4:285-290. Improving somatic gene expression by altering chromosomal sequences has been a prime goal of gene therapy. The authors provide the exciting information that they can mutate specific chromosomal sequences via the injection of an artificial oligonucleotide. This model may well be the best hope yet to reliably and safely deliver permanent changes to hepatic genes possessing single nucleotide mutations.